UK results from 36-month XTEND study show that proactive intravitreal aflibercept treatment for nAMD delivered and maintained meaningful visual and anatomical gains through 24 months, despite challenges of the COVID-19 pandemic.#Ophthalmology #OpenAccess.

Since their introduction, the use of large language models (LLMs) have gained widespread interest, especially in the medical field. This review highlights original research articles on how LLM’s can be utilised in #ophthalmology. . @pheyemd #AI

Study compares traditional methods with smartphone-based tools for measuring orbital implant motility post-enucleation. ImageJ is a reliable alternative to standard rule measurement, enabling accessible, home-based assessments. @DrNohaMS #Ophthalmology

EYE OPEN: Study compares research output on diabetic retinopathy vs sickle cell retinopathy. DR dominates publications (69k vs 1k), driven by high-income countries. SCR research lags, with limited contributions from Africa & the Caribbean. #Ophthalmology.

Myopia is a leading cause of vision impairment worldwide. This review outlines current and emerging strategies for myopia control, from optical & drug therapies to lifestyle & novel light treatments. Read #OpenAccess here: #Ophthalmology

High success, low recurrence: A Johannesburg study found that a size-based approach to OSSN treatment (excision for small tumours, topical 5FU for larger) achieved >70% complete resolution and <1% recurrence for excision cases. #Ophthalmology.

RT @PCONews: 💡An analysis of #optometrist-performed #SLT in the U.K. showed success rates upward of 65% and a 2.2% rate of adverse events.….

RT @RCOphth: Exciting news!.Our thanks to College member Patrick Yu-Wai-Man for his work on the NICE appraisal.

Sickle cell retinopathy leads to vision loss but is less recognised than diabetic retinopathy. Our study highlights global research trends and funding disparities, advocating for more focus on SCR for health equity. #OpenAccess #Ophthalmology. @Msfuseini

Even in early/intermediate AMD, structural retinal changes on OCT are linked to reduced visual function under bright & low light. These findings highlight key imaging markers of functional decline before advanced disease. #Ophthalmology #OpenAccess.

Check out our 'Clinical Trials at a Glance' collection. An impressive online gallery of 50+ infographics summarising major #Ophthalmology trials. Everything you need to know at a glance - perfect for clinicians, researchers & educators. ➡️

Key challenges in UK’s Certification of Vision Impairment. Authors present CVI numbers in England and Wales, current challenges in the pathway, a new proposed CVI form for England, certification by optometrists in Wales, & updates from NI. #Ophthalmology .

Oxford Eye Hospital has pioneered a minimalist, evidence-based approach to reduce intravitreal injection waste, cutting 3+ tonnes of waste & saving up to £180k annually without compromising safety. #Sustainability #Ophthalmology #OpenAccess.

Diabetic retinopathy causes vision loss partly due to retinal non-perfusion, which current treatments don't address. The Sema3A/Nrp1 pathway is emerging as a key factor in RNP. Targeting it could preserve vision, and reduce treatment burden.#OpenAccess

Review: Corneal transplantation has advanced rapidly, with selective techniques like DSAEK, DMEK, and DALK now the gold standard. Advancements in bio-engineered corneas and cell-based therapies will help overcome barriers in donor supply. #Ophthalmology

Patients in Europe face delays in accessing retinal treatments due to unclear clinical endpoint guidelines. The BRIDGE initiative aims to align EU and global standards, speeding up access through consensus on meaningful, patient-focused outcomes.

Now in EYE OPEN:. Most racial and ethnic groups lack representation in ophthalmology clinical trials. This study evaluates whether initiatives implemented by Roche/Genentech since 2017 have improved clinical trial demographic diversity. Read #OpenAccess:

RT @Albinism_MythX: Depth perception issues explained @AlbinismUK @RNIB @Moorfields .

RT @RCOphth: We're happy to be supporting #SASsix.

NEW Open Collection - Sustainability in Ophthalmology. Discover how #Ophthalmology is evolving to meet today’s environmental, economic, and social challenges. We welcome further submissions on this important topic.